[1]肖艳新,马朝朋,吴晓丹,等.5:2轻断食对代谢综合征患者体重及糖脂代谢的影响[J].国际内分泌代谢杂志,2023,43(03):242-246.[doi:10.3760/cma.j.cn121383-20220223-02054]
　Xiao Yanxin,Ma Zhaopeng,Wu Xiaodan,et al.Effect of 5:2 fasting diet on body weight and glucose and lipid metabolism in patients with metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(03):242-246.[doi:10.3760/cma.j.cn121383-20220223-02054]
点击复制

5:2轻断食对代谢综合征患者体重及糖脂代谢的影响()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年03期
页码:
242-246
栏目:
论著
出版日期:
2023-05-20

文章信息/Info

Title:
Effect of 5:2 fasting diet on body weight and glucose and lipid metabolism in patients with metabolic syndrome
作者:
肖艳新1; 马朝朋1; 吴晓丹1; 王红素2; 王君1
1保定市第一中心医院内分泌科,保定 071000; 2解放军陆军第82集团军医院放射科,保定 071000
Author(s):
Xiao Yanxin1;  Ma Zhaopeng1;  Wu Xiaodan1;  Wang Hongsu2;  Wang Jun1.
1Department of Endocrinology,Baoding NO.1 Central Hospital, Baoding 071000, China; 2Department of Radiology, the 82nd Army Hospital of the PLA, Baoding 071000, China
关键词:
5:2轻断食;  代谢综合征;  肥胖
Keywords:
5:2 intermittent fasting diet;  Metabolic syndrome;  Obesity
DOI:
10.3760/cma.j.cn121383-20220223-02054
摘要:
目的 观察5:2轻断食对肥胖代谢综合征患者体重及糖脂代谢的影响。方法 选取肥胖代谢综合征患者56例,分为5:2轻断食治疗组(n=36)及一般饮食控制治疗组(n=20),给予5:2轻断食及一般饮食控制治疗16周。观察治疗后患者身体形态指标和代谢指标变化。结果 治疗16周后,5:2轻断食治疗组各身体形态指标包括体重、体重指数、腰围、骨骼肌、体脂肪、体脂率、内脏脂肪面积均较治疗前显著下降(P<0.05); 代谢指标包括收缩压、舒张压、总胆固醇、低密度-脂蛋白胆固醇、甘油三酯、空腹血糖、餐后2 h血糖、尿酸及稳态模型-胰岛素抵抗指数(HOMA-IR)水平较治疗前显著下降,高密度脂蛋白-胆固醇水平显著升高(P<0.05)。与一般饮食控制治疗组比较,5:2轻断食治疗组在治疗16周后体重指数、体脂肪、体脂率及内脏脂肪面积、收缩压、舒张压、低密度脂蛋白-胆固醇、甘油三酯、空腹血糖、餐后2 h血糖、HOMA-IR水平更低(P<0.05)。治疗16周后,5:2轻断食治疗组肥胖、血脂异常、高尿酸血症、糖代谢异常及非酒精性脂肪肝比例较治疗前下降(P<0.05)。结论 5:2轻断食能够降低代谢综合征患者的体重、体脂率,改善糖脂代谢紊乱,减轻胰岛素抵抗,且优于一般饮食控制治疗。
Abstract:
Objective To observe the effect of 5:2 intermittent fasting diet on body weight and metabolic profile in patients with metabolic syndrome.Methods A total of 56 obese patients with metabolic syndrome were divided into 5:2 intermittent fasting treatment group(n=36)and general diet control treatment group(n=20). Patients in each group received 5:2 intermittent fasting and general diet control for 16 weeks. Body shape indexes and metabolic profile were observed after treatment.Results After 16 weeks of treatment, all body shape indexes such as body mass index, waist circumference, skeletal muscle content, body fat, body fat rate and visceral fat area in the 5:2 intermittent fasting treatment group decreased significantly compared with those before treatment(P<0.05). The levels of metabolic profile including systolic blood pressure, diastolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, triglycerides, fasting blood glucose, 2 hour postprandial blood glucose, uric acid and HOMA-IR decreased significantly compared with those before treatment, and the level of high-density lipoprotein cholesterol increased significantly(P<0.05). Compared with general diet control group, body mass index, body fat, body fat rate and visceral fat area, systolic blood pressure, diastolic blood pressure, low density lipoprotein cholesterol, triglyceride, fasting blood glucose, 2 hour postprandial blood glucose and HOMA-IR level in the 5:2 intermittent fasting treatment group were lower after 16 weeks of treatment(P<0.05). After 16 weeks of treatment, the proportion of obesity, dyslipidemia, hyperuricemia, abnormal glucose metabolism and nonalcoholic fatty liver disease in the 5:2 intermittent fasting treatment group decreased compared with that before treatment(P<0.05).Conclusions 5:2 intermittent fasting diet can reduce body weight and body fat ratio of patients with metabolic syndrome, improve the disorder of glucose and lipid metabolism and reduce insulin resistance, and is better than general diet control treatment.

参考文献/References:

[1] Saklayen MG.The global epidemic of the metabolic syndrome[J].Curr Hypertens Rep,2018,20(2):12.DOI:10.1007/s11906-018-0812-z.
[2] Lee SJ,Shin SW.Mechanisms,pathophysiology,and management of obesity[J].N Engl J Med,2017,376(15):1491-1492.DOI:10.1056/NEJMc1701944.
[3] Promrat K,Kleiner DE,Niemeier HM,et al.Randomized controlled trial testingthe effects of weight loss on nonalcoholic steatohepatitis[J].Hepatology,2010,51(1):121-129.DOI:10.1002/hep.23276.
[4] Carter S,Clifton PM,Keogh JB.The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial[J].Diabetes Res Clin Pract,2016,122:106-112.DOI:10.1016/j.diabres.2016.10.010.
[5] Pérez-Martínez P,Mikhailidis DP,Athyros VG,et al.Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation[J].Nutr Rev,2017,75(5):307-326.DOI:10.1093/nutrit/nux014.
[6] Seo MH,Kim YH,Han K,et al.Prevalence of obesity and incidence of obesity-related comorbidities in koreans based on national Health insurance service health checkup data 2006-2015[J].J Obes Metab Syndr,2018,27(1):46-52.DOI:10.7570/jomes.2018.27.1.46.
[7] Durrer Schutz D,Busetto L,Dicker D,et al.European practical and patient-centred guidelines for adult obesity management in primary care[J].Obes Fact,2019,12(1):40-66.DOI:10.1159/000496183.
[8] Moore MP,Cunningham RP,Dashek RJ,et al.A fad too far? Dietary strategiesfor the prevention and treatment of NAFLD[J].Obesity(Silver Spring),2020,28(10):1843-1852.DOI:10.1002/oby.22964.
[9] Rynders CA,Thomas EA,Zaman A,et al.Effectiveness of intermittent fasting and time-restricted feeding compared to continuous energy restriction for weigt loss[J].Nutrients,2019,11(10):2442.DOI:10.3390/nu11102442.
[10] Ross R,Freeman J,Hudson R,et al.Abdominal obesity, muscle composition,and insulin resistance in premenopausal women[J].J Clin Endocrinol Metab,2002,87(11):5044-5051.DOI:10.1210/jc.2002-020570.
[11] Barnosky AR,Hoddy KK,Unterman TG,et al.Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention:a review of human findings[J].Transl Res,2014,164(4):302-311.DOI:10.1016/j.trsl.2014.05.013.
[12] Byrne NM,Sainsbury A,King NA,et al.Intermittent energy restriction improves weight loss efficiency in obese men:the MATADOR study[J].Int J Obes(Lond),2018,42(2):129-138.DOI:10.1038/ijo.2017.206.
[13] Corley BT,Carroll RW,Hall RM,et al.Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia:a randomized controlled trial[J].Diabet Med,2018,35(5):588-594.DOI:10.1111/dme.13595.
[14] Holmer M,Lindqvist C,Petersson S,et al.Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet-a randomised controlled trial[J].JHEP Rep,2021,3(3):100256.DOI:10.1016/j.jhepr.2021.100256.
[15] Pinto AM,Bordoli C,Buckner LP,et al.Intermittent energy restriction is comparable to continuous energy restriction for cardiometabolic health in adults with central obesity:a randomized controlled trial; the Met-IER study[J].Clin Nutr,2020,39(6):1753-1763.DOI:10.1016/j.clnu.2019.07.014.
[16] Carter S,Clifton PM,Keogh JB.Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial[J].JAMA Netw Open,2018,1(3):e180756.DOI:10.1001/jamanetworkopen.2018.0756.
[17] Cai H,Qin YL,Shi ZY,et al.Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease:a randomised controlled trial[J].BMC Gastroenterol, 2019,19(1):219.DOI:10.1186/s12876-019-1132-8.
[18] Kunduraci YE,Ozbek H.Does the energy restriction intermittent fasting diet alleviate metabolic syndrome biomarkers? A randomized controlled trial[J].Nutrients,2020,12(10):3213.DOI:10.3390/nu12103213.
[19] Schübel R,Nattenmüller J,Sookthai D,et al.Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk:a randomized controlled trial[J].Am J Clin Nutr,2018,108(5):933-945.DOI:10.1093/ajcn/nqy196.

相似文献/References:

[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
　Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(03):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]杨雪,时立新,张巧,等.中老年人群25-羟维生素D3与代谢综合征的 相关性分析[J].国际内分泌代谢杂志,2014,(05):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
　Yang Xue*,Shi Lixin,Zhang Qiao,et al.Association between 25-hydroxyvitamin D3 and metabolic syndrome in middle-aged and elderly population[J].International Journal of Endocrinology and Metabolism,2014,(03):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
[3]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
　Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(03):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[4]王姝洁,张翼飞,张志国.雷公藤红素在治疗代谢综合征中的作用及相关机制[J].国际内分泌代谢杂志,2017,37(04):258.
　Wang Shujie,Zhang Yifei,Zhang Zhiguo..Effects and related mechanisms of celastrol in the treatment of metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(03):258.
[5]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
　Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(03):270.
[6]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群 糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298.
　Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(03):298.
[7]谢幸 陈树春 朱海娇 刘阳 王幸.蛙皮素样受体亚型-3与代谢综合征[J].国际内分泌代谢杂志,2018,38(03):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
　Xie Xing*,Chen Shuchun,Zhu Haijiao,et al.Bombesin receptor subtype-3 and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(03):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
[8]聂秀玲.长期果糖摄入与代谢综合征[J].国际内分泌代谢杂志,2018,38(05):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
　Nie Xiuling.Chronic fructose intake and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(03):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
[9]肖扬 徐书杭 黄华英 郭玲 吕文君 冯宁霞 汪奇峰 茅晓东 陈国芳 刘超.常州地区青少年人群不同代谢综合征诊断标准的比较研究[J].国际内分泌代谢杂志,2020,40(01):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
　Xiao Yang,Xu Shuhang,Huang Huaying,et al.A comparative study of the different diagnostic criteria for metabolic syndrome among adolescents in Changzhou area[J].International Journal of Endocrinology and Metabolism,2020,40(03):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
[10]王应昉 曹璐 陈凤 许帅 陈风 郭妍 王岩 王涤非.社区老年居民握力体重指数与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(01):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]
　Wang Yingfang,Cao Lu,Chen Feng,et al.Relationship between handgrip strength body mass index and metabolic syndrome in community elderly residents[J].International Journal of Endocrinology and Metabolism,2020,40(03):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]

备注/Memo

备注/Memo:
通信作者:王君,Email:Sunday47@163.com
更新日期/Last Update: 2023-05-20